Loading…
ICU Medical, Inc. is projected to rise to $185.60 by 2027, a +34% move from its current price of $138.34. ICUI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $135.82 | $138.40 | $141.03 | +0.04% |
| May 30 | $134.83 | $138.46 | $142.20 | +0.09% |
| May 31 | $134.08 | $138.53 | $143.12 | +0.13% |
| Jun 1 | $133.47 | $138.59 | $143.90 | +0.18% |
| Jun 2 | $132.93 | $138.65 | $144.61 | +0.22% |
| Jun 3 | $132.46 | $138.71 | $145.26 | +0.27% |
| Jun 4 | $132.03 | $138.77 | $145.86 | +0.31% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $132.03 | $138.77 | $145.86 | +0.31% |
| Week 2 | $129.74 | $139.21 | $149.37 | +0.63% |
| Week 3 | $128.10 | $139.65 | $152.23 | +0.94% |
| Week 4 | $126.80 | $140.08 | $154.76 | +1.26% |
| Week 5 | $125.71 | $140.52 | $157.08 | +1.58% |
| Week 6 | $124.78 | $140.97 | $159.26 | +1.90% |
| Week 7 | $123.95 | $141.41 | $161.32 | +2.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. Its product lines include Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClave for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products.
The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services.
The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
ICU Medical, Inc. (ICUI) is a healthcare company currently trading at $133.31. It operates in infusion therapy, vascular access, and vital care product categories.
Its market capitalization is $3.33B and the stock is ranked 1638. The stock shows a mixed longer‑term outlook, with a 2026 forecast averaging $133.31 and a range from $115.45 to $183.29, signaling a neutral near term trajectory.
A major floor 22.1% below — a decisive break under it would weaken the trend.
The nearest floor, 16.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 14.6% above — clearing it would confirm fresh momentum.
Key ICUI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ICUI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $133.45 | Buy | $133.48 | Buy |
| MA 10 | $127.77 | Buy | $129.93 | Buy |
| MA 20 | $124.20 | Buy | $127.17 | Buy |
| MA 50 | $125.49 | Buy | $128.07 | Buy |
| MA 100 | $136.38 | Buy | $131.58 | Buy |
| MA 200 | $133.58 | Buy | $134.26 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 68.39 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 192.51 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 2.02 | Buy |
| ROC (12) | 9.42 | Buy |
| Bollinger %B (20,2) | 1.08 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 8.33 | Buy |
| Ultimate (7,14,28) | 87.35 | Sell |
| Momentum (10) | 15.11 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 138.07 | Buy |
| ADX (14) | 16.60 | Neutral |
| ATR (14) | 2.43 | Info |
The 30-day technical picture is bullish. The overall sentiment aligns with that view, reflecting constructive near-term dynamics.
RSI14 is 60, indicating moderate momentum. SMA50 sits at $125.08 and SMA200 is at $133.43, providing nearby trend anchors for support and longer-term context.
Support is seen at $115.45 and resistance at $133.31. The 30-day price range extends from $117.49 to $151.26, illustrating how recent price action has oscillated within that band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $115.45 | $138.34 | $188.88 | 0% | Neutral | |
| $151.63 | $185.60 | $237.82 | +34% | Bullish | |
| $152.28 | $189.81 | $249.56 | +37% | Bullish | |
| $161.59 | $204.46 | $274.41 | +48% | Bullish | |
| $175.29 | $224.75 | $306.98 | +62% | Bullish | |
| $180.08 | $233.69 | $324.16 | +69% | Bullish | |
| $207.92 | $272.83 | $383.77 | +97% | Bullish | |
| $238.80 | $316.62 | $451.09 | +129% | Bullish | |
| $256.14 | $342.97 | $494.41 | +148% | Bullish | |
| $266.65 | $360.40 | $525.28 | +161% | Bullish | |
| $386.59 | $544.89 | $832.00 | +294% | Bullish | |
| $608.25 | $919.31 | $1,504.25 | +565% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $115.45 | $138.34 | $162.34 | +0.00% |
| June 2026 | $122.80 | $143.25 | $170.35 | +3.55% |
| July 2026 | $122.82 | $144.10 | $172.99 | +0.60% |
| August 2026 | $121.13 | $142.77 | $172.63 | -0.93% |
| September 2026 | $123.78 | $146.43 | $178.10 | +2.56% |
| October 2026 | $127.64 | $151.50 | $185.27 | +3.47% |
| November 2026 | $127.55 | $151.86 | $186.58 | +0.23% |
| December 2026 | $128.19 | $153.05 | $188.88 | +0.78% |
Click any year to see its month-by-month ICUI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ICUI to range from $115.45 to $188.88 through 2026. The $138.34 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The ICUI price prediction for 2027 points to an average of $185.60 (low $151.63, high $237.82) — a potential gain of +34% on today's $138.34. Momentum favours further upside here.
In 2028, ICUI is projected to trade between $152.28 and $249.56, averaging $189.81 — a potential gain of +37% from today's $138.34. That is up +2% on the projected 2027 average. Buyers look set to stay in control over this stretch.
ICU Medical, Inc.'s 2029 outlook centres on $204.46, within a $161.59 to $274.41 range. That is up +8% on the projected 2028 average. That marks a +48% change versus current levels. Momentum favours further upside here.
By 2030, ICUI could reach as high as $306.98, with a base case around $224.75 and support toward $175.29 — roughly +62% from $138.34. Buyers look set to stay in control over this stretch.
Expect ICUI to range from $180.08 to $324.16 through 2031. The $233.69 average target implies a +69% move from current prices. That is up +4% on the projected 2030 average. Momentum favours further upside here.
The ICUI price prediction for 2032 points to an average of $272.83 (low $207.92, high $383.77) — a potential gain of +97% on today's $138.34. Buyers look set to stay in control over this stretch.
In 2033, ICUI is projected to trade between $238.80 and $451.09, averaging $316.62 — a potential gain of +129% from today's $138.34. That is up +16% on the projected 2032 average. Momentum favours further upside here.
ICU Medical, Inc.'s 2034 outlook centres on $342.97, within a $256.14 to $494.41 range. That is up +8% on the projected 2033 average. That marks a +148% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, ICUI could reach as high as $525.28, with a base case around $360.40 and support toward $266.65 — roughly +161% from $138.34. Momentum favours further upside here.
Expect ICUI to range from $386.59 to $832.00 through 2040. The $544.89 average target implies a +294% move from current prices. That is up +51% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The ICUI price prediction for 2050 points to an average of $919.31 (low $608.25, high $1,504.25) — a potential gain of +565% on today's $138.34. Momentum favours further upside here.
Investing $1,000 in ICUI today (≈ 7.228567 ICUI) could be worth
$6,645.32
+$5,645.32 (+565%) by 2050 · US Dollar
Based on the average projected ICUI price of $919.31 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ICUIwould be worth at today's price.
$1,000 invested in ICUI on May 27, 2025 (≈ 7.66636 ICUI) would be worth
$1,060.56
+$60.56 (+6.1%) today · 1.06× · US Dollar
Based on a ICUI entry price of $130.44 vs. today's $138.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $129.31 | $1,069.83 | +7.0% |
| 1 month ago | $122.85 | $1,126.09 | +12.6% |
| 3 months ago | $150.82 | $917.25 | -8.3% |
| 6 months ago | $148.44 | $931.96 | -6.8% |
| 1 year ago | $130.44 | $1,060.56 | +6.1% |
| All time (5.0y) ago | $206.49 | $669.96 | -33.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ICUI forecast.
Our base-case forecast reaches $280.00 around 2033.
Implied market cap at $280.00: $7B
The multi-year forecast shows a bullish trajectory across the horizon, with rising averages and expanding upside. For example, 2027 is projected at an avg of $179.50, 2028 at $182.46, and 2029 at $198.03, leading to 2030 with an avg of $218.04 and a max of $298.64 (ROI 63.6%), all signaling stronger longer-term momentum.
The 2040 forecast strengthens further, with an avg of $525.46 and a max of $805.66 (ROI 294.2%), highlighting substantial upside potential if momentum sustains. The 2050 forecast shows an avg of $895.19 and a max of $1,472.05 (ROI 571.5%), with sentiment remaining bullish.
These figures are estimates and illustrate potential paths, not guarantees. Real-world outcomes depend on a range of factors and market conditions that can affect performance over extended horizons.
Tap a question to reveal the answer.
The 2030 forecast shows min $169.69, avg $218.04, max $298.64, with an estimated ROI of 63.6% and bullish sentiment.
The forecast is bullish from 2027 onward, with rising averages and higher potential, though 2026 is neutral.
The max forecast for 2030 is $298.64, which is slightly below $300.
Avg $895.19, max $1,472.05, min $589.10, ROI 571.5%, sentiment bullish.
Current price $133.31; market cap $3.33B.
ICU Medical, Inc. Community Discussion
0Share your ICU Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.